Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study. The new standard is more effective at preventing GVHD and came with less side effects, compared with the current gold standard.
Click here for original story, Study sets new standard for graft-versus-host disease prevention after stem cell transplant
Source: ScienceDaily